World-renowned experts in the management of hematologic malignancies present the latest treatment advances, updates to the standard of care as recommended in the NCCN Guidelines®, and unique and challenging patient cases. Chaired by Andrew D. Zelenetz, MD, PhD, from Memorial Sloan Kettering Cancer Center, this program features presentations and interactive discussions highlighting the treatment options and supportive...

LEAD is a conference designed for women in oncology and hematology. The goal of this conference is to empower women leaders in the hematology and oncology space by providing essential clinical updates, career development, and professional networking. Sessions include discussions on the importance of women’s leadership, career development workshops, and clinical sessions on biomarkers and...

The Immuno-Oncology Symposium aims to bring together oncology professionals, researchers, and industry leaders to explore the latest advancements in immuno-oncology and its optimal clinical application. With a focus on cutting-edge technologies, this conference offers a unique opportunity to gain insights into the rapidly evolving field of immuno-oncology. This event will be available both in-person and...

Program Goals & Content Overview As new clinical data continues to emerge as a result of ongoing research in breast cancer diagnostics and therapeutics, official Best of SABCS® programs cover these important developments in each of the live, regional events. Each regional event provides an educational forum for local researchers and clinicians to discuss the...

We are delighted to announce the upcoming three-day course, the  Clinical Cancer Update, scheduled to commence on Friday, February 2nd.  This year's conference is a comprehensive and dynamic platform designed to provide healthcare professionals with a deep dive into the latest advances in the treatment, early detection, and prevention of a wide range of cancers....

Overview The 2024 Steven Coutre Review of the 65th ASH (American Society of Hematology) Meeting is a highly anticipated event that will showcase the latest research and data on hematologic disorders. The review aims to provide healthcare professionals with updated treatment algorithms and strategies that are geared towards optimizing the care of their patients. This...

This conference will present the most current information on multidisciplinary approaches in clinical oncology and will consist of tumor board cases on breast, gastrointestinal, genitourinary,  hematologic malignancies, lymphoma, and thoracic cancers. The tumor board cases will be presented by faculty, with discussion by a panel of surgical, radiation, and medical oncologists from Stanford, UC Davis,...

Save the Date! 2024 Stanford Blood and Marrow Transplantation and Cancer Cell Therapy Symposium Arrillaga Alumni Center/Hybrid April 4-5, 2024 The Department of Blood & Marrow Transplantation at the Stanford University School of Medicine invites you to save the date for this upcoming program. Full program details to follow.   Interested in hearing about upcoming Stanford...

ANCO's Hematologic Malignancies Update 2024 will take place May 4th & 5th at the Hyatt Regency Monterey Bay, The faculty will present the latest research on treatment modalities for hematologic malignancies—leukemias, lymphomas, and myeloma—along with case studies for these diagnoses. Learn More Program Information and Registration: Register Here Please Note: ANCO has secured a discounted...